Concepedia

William M. Moore

WM

77

Publications

5.4K

Citations

37

H-Index

1966

Active since

Affiliations

Monsanto (United States)(Current)

University of Manchester

Pfizer (United States)

University of Alabama at Birmingham

Lexington Medical Center

William M. Moore is an author at Monsanto (United States) specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1966–2021

77

Publications

77

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

Thomas P. Misko, William M. Moore, Thomas P. Kasten et al. · European Journal of Pharmacology · 1993 · 724 citations

, , +7

L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase

William M. Moore, R. Keith Webber, Gina Jerome et al. · Journal of Medicinal Chemistry · 1994 · 459 citations · Full text

Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase

Jane R. Connor, Pamela T. Manning, Steven L. Settle et al. · European Journal of Pharmacology · 1995 · 301 citations

, , +14

Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation

Ronald G. Tilton, Katherine Chang, Khalid S. Hasan et al. · Diabetes · 1993 · 288 citations

Head Circumference Reference Data: Birth to 18 Years

Alex F. Roche, Debabrata Mukherjee, Shumei Guo et al. · PEDIATRICS · 1987 · 236 citations

, , +13

Rows per page

1–5 of 77